Results 321 to 330 of about 3,243,106 (373)

Correction: Immunopeptidomics reveals determinants of <i>Mycobacterium tuberculosis</i> antigen presentation on MHC class I.

Elife
Leddy O, White FM, Bryson BD.
europepmc   +1 more source

High Levels of Endogenous Omega-3 Fatty Acids Promote Dendritic Cell Antigen Presentation and Improve Dendritic Cell-Based Cancer Vaccine Efficacy in Mice. [PDF]

Cancer Immunol Res
Tiwary S, Hsu KS, Goldfarbmuren KC, Xia Z, Berzofsky JA.   +4 more
europepmc   +1 more source

Generation of an Induced Pluripotent Stem Cell‐Derived Alveolar Type II In Vitro Model to Study Influenza A Virus Infection and Drug Treatments

Advanced Healthcare Materials, EarlyView.
Patient‐specific induced pluripotent stem cells (iPSCs) can be differentiated into alveolar type II cells (iAT2s), expanded as 3D alveolospheres, and grown at physiologically relevant air–liquid interface (ALI). This study shows for the first time the infectability of iAT2s by the influenza A virus (IAV) and proves their responsiveness to the well ...
Lena Gauthier, Hristina Koceva, Yann Bachelot, Rosanne W. Koutstaal, Puck B. van Kasteren, Marc Thilo Figge, Christian Eggeling, Alexander Sandy Mosig   +7 more
wiley   +1 more source

A synthetic cyclic peptide for promoting antigen presentation and immune activation. [PDF]

NPJ Vaccines
Zhang J, Madge HYR, Mahmoud A, Lu L, Wang W, Huang W, Koirala P, Gonzalez Cruz JL, Kong WY, Bashiri S, Shalash AO, Hussein WM, Khalil ZG, Wells JW, Toth I, Stephenson RJ.   +15 more
europepmc   +1 more source

Astrocytic lipid droplets contain MHCII and may act as cogs in the antigen presentation machinery. [PDF]

J Neuroinflammation
Beretta C, Dakhel A, Eltom K, Rosqvist F, Uzoni S, Mothes T, Fletcher JS, Risérus U, Sehlin D, Rostami J, Michno WP, Erlandsson A.   +11 more
europepmc   +1 more source

Keratinocyte-Mediated Antigen Presentation in Psoriasis: Preliminary Insights from In Vitro Studies. [PDF]

Int J Mol Sci
Zima K, Purzycka-Bohdan D, Szczerkowska-Dobosz A, Gabig-Cimińska M.   +3 more
europepmc   +1 more source

AMPK-dependent Parkin activation suppresses macrophage antigen presentation to promote tumor progression. [PDF]

Sci Adv
Wang X, Li Y, Li Y, Wang X, Song H, Wang Y, Huang C, Mao C, Wang L, Zhong C, Yu D, Xia Z, Feng Y, Duan J, Liu Y, Ou J, Luo C, Mai W, Hong H, Cai W, Zheng L, Trempe JF, Fon EA, Liao J, Yi W, Chen J.   +25 more
europepmc   +1 more source

Blocking Feedback Immunosuppression of Antigen Presentation in Brain Tumor During Oncolytic Virotherapy with oHSV-mshPKR. [PDF]

Mol Cancer Ther
Tsuboi N, Rivera-Caraballo KA, Sahu U, Pacholczyk R, Douglass E, Johnson TS, Wang Q, Kolhe R, Hedrick CC, Munn DH, Hong B.   +10 more
europepmc   +1 more source

Presentation by antigen following topical DMBA treatment is mediated by newly arrived Langerhans cells

, 1998
Kathleen Doherty, GM Woods, Muller, HK (15477911)   +2 more
openalex  

Tetrandrine decreases Mtb antigen presentation.

Elham Karamooz (2584474), Se-Jin Kim (739053), Jessie C. Peterson (21983062), Allison E. Tammen (21983065), Shogo Soma (429657), Aviva C.R. Soll (21983068), Erin W. Meermeier (10575377), Sharon Khuzwayo (10575374), David M. Lewinsohn (8948450)   +8 more
openalex   +1 more source